Paula Soteropoulos Insider Trading $AKCA AKCEA THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paula Soteropoulos.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paula Soteropoulos. Paula Soteropoulos is Director in uniQure N.V. ($QURE) and Chief Executive Officer in AKCEA THERAPEUTICS, INC. ($AKCA) and President & CEO in AKCEA THERAPEUTICS, INC. ($AKCA).
Paula Soteropoulos in AKCEA THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paula Soteropoulos: Chief Executive Officer, President & CEO
Holdings: 1,711,079 shares
Latest Transaction: Sep 30 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paula Soteropoulos in AKCEA THERAPEUTICS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 12.21 | 205,479 | 2,508,899 | 102,740 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 145,303 | 941,563 | 13,209 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 1,711,079 | 11,087,792 | 0 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Payment of Exercise | F | 16.64 | 175,064 | 2,913,065 | 678,149 | 853.2 K to 678.1 K (-20.52 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 12.21 | 205,479 | 2,508,899 | 853,213 | 647.7 K to 853.2 K (+31.72 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Payment of Exercise | F | 16.64 | 95,156 | 1,583,396 | 647,734 | 742.9 K to 647.7 K (-12.81 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 145,303 | 941,563 | 742,890 | 597.6 K to 742.9 K (+24.31 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Payment of Exercise | F | 16.64 | 1,113,492 | 18,528,507 | 597,587 | 1.7 M to 597.6 K (-65.08 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 1,711,079 | 11,087,792 | 1,711,079 | 0 to 1.7 M |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 1,787 | 11,580 | 1,711,079 | |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 30,000 | 194,400 | 1,712,866 | |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Sell | S | 32.17 | 1,787 | 57,480 | 0 | 1.8 K to 0 (-100.00 %) |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 1,787 | 11,580 | 1,787 | 0 to 1.8 K |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Sell | S | 32.11 | 30,000 | 963,300 | 0 | 30 K to 0 (-100.00 %) |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 30,000 | 194,400 | 30,000 | 0 to 30 K |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 1,787 | 11,580 | 1,711,079 | |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 30,000 | 194,400 | 1,712,866 | |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Sell | S | 32.17 | 1,787 | 57,480 | 0 | 1.8 K to 0 (-100.00 %) |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 1,787 | 11,580 | 1,787 | 0 to 1.8 K |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Sell | S | 32.11 | 30,000 | 963,300 | 0 | 30 K to 0 (-100.00 %) |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 30,000 | 194,400 | 30,000 | 0 to 30 K |
| Mar 07 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 18,386 | 119,141 | 1,742,866 | |
| Mar 07 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Sell | S | 32.14 | 18,386 | 590,856 | 0 | 18.4 K to 0 (-100.00 %) |
| Mar 07 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 18,386 | 119,141 | 18,386 | 0 to 18.4 K |
| Jan 04 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | A | 30.73 | 296,000 | 9,096,080 | 296,000 | |
| Jan 04 2018 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | President & CEO | Option Exercise | A | 17.38 | 275,000 | 4,779,500 | 275,000 |
Page: 1